Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.
about
Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic StrokeFate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?The ischemic environment drives microglia and macrophage functionDeveloping Cellular Therapies for StrokeMesenchymal stem cells engineered to express selectin ligands and IL-10 exert enhanced therapeutic efficacy in murine experimental autoimmune encephalomyelitis.Nicotinamide Administration Improves Remyelination after Stroke.Mesenchymal stromal cells in stroke: improvement of motor recovery or functional compensation?The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocityImmunogenicity of decidual stromal cells in an epidermolysis bullosa patient and in allogeneic hematopoietic stem cell transplantation patientsEffects of Mesenchymal Stem Cell Treatment on the Expression of Matrix Metalloproteinases and Angiogenesis during Ischemic Stroke Recovery.Stem Cell-Based Tissue Replacement After Stroke: Factual Necessity or Notorious Fiction?Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPAElectric stimulation of the ears ameliorated learning and memory impairment in rats with cerebral ischemia-reperfusion injury.Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia.Initiation and early control of tissue regeneration - bone healing as a model system for tissue regeneration.Brain mesenchymal stem cells: The other stem cells of the brain?Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.Safety and effectiveness of stem cell therapies in early-phase clinical trials in stroke: a systematic review and meta-analysisThe 3 Rs of Stroke Biology: Radial, Relayed, and Regenerative.Intravenous infusion of human bone marrow mesenchymal stromal cells promotes functional recovery and neuroplasticity after ischemic stroke in mice.Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered.The Dose of Intravenously Transplanted Bone Marrow Stromal Cells Determines the Therapeutic Effect on Vascular Remodeling in a Rat Model of Ischemic Stroke.Role of Helicobacter pylori on cancer of human adipose-derived mesenchymal stem cells and metastasis of tumor cells-an in vitro study.Multipotent neural crest stem cell-like cells from rat vibrissa dermal papilla induce neuronal differentiation of PC12 cellsStem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.Lentivirus-mediated transfection of chondroitinase ABC gene without the bacterial leader sequence enables long-term secretion of functional chondroitinase ABC in human bone marrow stromal cells.The long-term fate of mesenchymal stem cells labeled with magnetic resonance imaging-visible polymersomes in cerebral ischemia.In Vitro Differentiation of Bone Marrow Mesenchymal Stem Cells into Neuron-Like Cells by Cerebrospinal Fluid Improves Motor Function of Middle Cerebral Artery Occlusion RatsWhite Matter Repair After Extracellular Vesicles Administration in an Experimental Animal Model of Subcortical StrokePriming of the Cells: Hypoxic Preconditioning for Stem Cell TherapyThe effect of injection using narrow-bore needles on mammalian cells: administration and formulation considerations for cell therapiesEvaluation of Parametric Response Mapping to Assess Therapeutic Response to Human Mesenchymal Stem Cells after Experimental Stroke.Intra-arterial transplantation of low-dose stem cells provides functional recovery without adverse effects after stroke.Recent Advances in Stem Cell-Based Therapeutics for Stroke.Bone Morphogenetic Protein 2 Alters Osteogenesis and Anti-Inflammatory Profiles of Mesenchymal Stem Cells Induced by Microtextured Titanium In Vitro.The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke.Concise Review: Extracellular Vesicles Overcoming Limitations of Cell Therapies in Ischemic Stroke.Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.Qualitative and quantitative analysis of MR imaging findings in patients with middle cerebral artery stroke implanted with mesenchymal stem cells.
P2860
Q26776494-14B4F805-09DF-4828-9850-DB1318579C60Q27692601-29E1F1E7-E11B-4BA6-97C9-E0C88748BEC4Q28086874-C2E43EB7-6E7A-4D00-BCB1-82BA6B76B59BQ28087451-ECDFE992-883D-42E9-B9E5-544ABBC23210Q30690412-02CFE6D9-4569-40F0-8CC3-DF1CD8D8CCFFQ33800897-009D4BFA-A195-4006-AC85-C71F73BAA0F4Q34018702-D42C6C8C-AEB2-4CE3-BD31-0084DB10A38CQ35631025-E26FA833-CAC7-4520-BA72-4CEDC30B2968Q35797175-1F538AE7-3FFF-484A-97CF-C0FB7F2AF46FQ35861206-D74989DE-7E61-4DEE-8CD5-8C7C3AB02C14Q35901180-53894396-790A-43F1-AA7A-9232AD4CD966Q36222296-AF5AD819-5155-4041-998D-A0B99626B1ADQ36548976-62C30C89-BB39-4A31-AF7F-ABB2E26BDB10Q37587747-F75A3B27-4141-40DC-B6E3-D21B311B8855Q38176443-97522438-658F-488C-9343-642A691E3D7AQ38207598-AF64422E-62C0-44D3-9735-601FFFF2B1A7Q38285864-B3A7530F-F3A3-4753-8976-E280359D8D68Q38353261-200186B6-8DAE-4AA1-A125-D9737FD639E0Q38601839-D103DF62-E246-452E-8BAA-2ED905069273Q38646400-5CE726E6-F035-4119-8478-E1D1E133597DQ38650671-4E4BAF13-0F52-451A-AC53-FEC79513B216Q38773427-3399C32B-D8C9-48FD-9A0E-B9140ECB9586Q38835646-27CEA112-F9A3-4512-A8A2-05C5209256A3Q38955493-2F7117B6-6C1E-4069-8319-DCDBD43F9EB9Q38973377-D4098273-39BF-4982-82A3-C9351E1C45D2Q39457984-C02D4D0E-F9D7-49CA-A00D-421309F8950DQ40890520-23EF2D94-71C9-4B46-8B3F-3A135823BA35Q41089568-C53A8EBE-41FD-40EE-BFC4-6FC7B213A781Q41586583-BC135E71-E6D5-45A8-BFC7-623D439EDB77Q42077691-79F30F5D-76A2-4440-ABFC-8E0BECD9179BQ42267329-0CCBEDC5-BFBB-41E9-BC11-781843E0FF26Q42396489-4B973958-DE9F-4CE4-859B-1C36E3E7C4D8Q43526355-90EF3893-4D9B-4824-89EC-DFE6754FF520Q44014320-5B598054-C309-4B19-9CF3-3119A9D2A4DAQ44836823-6D88EED1-3F81-4BF3-8BCC-A29107952196Q45055852-5249BF92-E470-4B9F-B9CF-FA5BF59DA1D7Q47190774-5180F4D1-9BE7-45C6-B71E-2359D4D6CDDFQ48100040-275DACAA-634E-450F-99D4-7DA3B7A886D8Q48337519-83DD0C54-91E9-4738-9367-68233399E0FBQ48342178-B9D92EC3-4A72-4E81-A887-5C4E66E873E4
P2860
Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evidence for high translationa ...... recovery from ischemic stroke.
@en
Evidence for high translationa ...... recovery from ischemic stroke.
@nl
type
label
Evidence for high translationa ...... recovery from ischemic stroke.
@en
Evidence for high translationa ...... recovery from ischemic stroke.
@nl
prefLabel
Evidence for high translationa ...... recovery from ischemic stroke.
@en
Evidence for high translationa ...... recovery from ischemic stroke.
@nl
P2093
P2860
P356
P1476
Evidence for high translationa ...... recovery from ischemic stroke
@en
P2093
Jingxia Yu
Steven C Cramer
Weian Zhao
Wenbin Liao
P2860
P304
P356
10.1038/JCBFM.2013.91
P577
2013-06-12T00:00:00Z